Luyan Pharma Statistics

Total Valuation

Luyan Pharma has a market cap or net worth of CNY 5.50 billion. The enterprise value is 10.20 billion.

Market Cap	5.50B
Enterprise Value	10.20B

Important Dates

The last earnings date was Tuesday, April 21, 2026.

Earnings Date	Apr 21, 2026
Ex-Dividend Date	Jul 10, 2025

Share Statistics

Luyan Pharma has 388.52 million shares outstanding. The number of shares has decreased by -0.32% in one year.

Current Share Class	388.52M
Shares Outstanding	388.52M
Shares Change (YoY)	-0.32%
Shares Change (QoQ)	-1.16%
Owned by Insiders (%)	3.50%
Owned by Institutions (%)	0.46%
Float	232.41M

Valuation Ratios

The trailing PE ratio is 19.67.

PE Ratio	19.67
Forward PE	n/a
PS Ratio	0.26
PB Ratio	1.69
P/TBV Ratio	2.12
P/FCF Ratio	12.10
P/OCF Ratio	7.99
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.89, with an EV/FCF ratio of 22.43.

EV / Earnings	36.31
EV / Sales	0.48
EV / EBITDA	13.89
EV / EBIT	17.07
EV / FCF	22.43

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	1.53
Debt / EBITDA	6.82
Debt / FCF	11.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 8.64% and return on invested capital (ROIC) is 11.71%.

Return on Equity (ROE)	8.64%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	11.71%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	3.12%
Revenue Per Employee	3.79M
Profits Per Employee	50,140
Employee Count	5,602
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Luyan Pharma has paid 97.25 million in taxes.

Income Tax	97.25M
Effective Tax Rate	25.85%

Stock Price Statistics

The stock price has increased by +72.43% in the last 52 weeks. The beta is 0.31, so Luyan Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+72.43%
50-Day Moving Average	15.06
200-Day Moving Average	12.39
Relative Strength Index (RSI)	40.99
Average Volume (20 Days)	65,283,863

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Luyan Pharma had revenue of CNY 21.25 billion and earned 280.88 million in profits. Earnings per share was 0.72.

Revenue	21.25B
Gross Profit	1.50B
Operating Income	597.30M
Pretax Income	376.23M
Net Income	280.88M
EBITDA	671.78M
EBIT	597.30M
Earnings Per Share (EPS)	0.72

Full Income Statement

Balance Sheet

The company has 459.18 million in cash and 5.00 billion in debt, giving a net cash position of -4.55 billion or -11.70 per share.

Cash & Cash Equivalents	459.18M
Total Debt	5.00B
Net Cash	-4.55B
Net Cash Per Share	-11.70
Equity (Book Value)	3.26B
Book Value Per Share	8.34
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 688.40 million and capital expenditures -233.74 million, giving a free cash flow of 454.66 million.

Operating Cash Flow	688.40M
Capital Expenditures	-233.74M
Depreciation & Amortization	76.46M
Net Borrowing	146.99M
Free Cash Flow	454.66M
FCF Per Share	1.17

Full Cash Flow Statement

Margins

Gross margin is 7.08%, with operating and profit margins of 2.81% and 1.32%.

Gross Margin	7.08%
Operating Margin	2.81%
Pretax Margin	1.77%
Profit Margin	1.32%
EBITDA Margin	3.16%
EBIT Margin	2.81%
FCF Margin	2.14%

Dividends & Yields

This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 2.47%.

Dividend Per Share	0.35
Dividend Yield	2.47%
Dividend Growth (YoY)	16.67%
Years of Dividend Growth	1
Payout Ratio	111.78%
Buyback Yield	0.32%
Shareholder Yield	2.85%
Earnings Yield	5.11%
FCF Yield	8.26%

Dividend Details

Stock Splits

The last stock split was on May 29, 2019. It was a forward split with a ratio of 1.7.

Last Split Date	May 29, 2019
Split Type	Forward
Split Ratio	1.7

Scores

Altman Z-Score	n/a
Piotroski F-Score	3